ATP2B1 rs17247383: Blood Pressure & Hypertension Link
The rs17247383 variant is a single nucleotide polymorphism located within the ATP2B1 gene locus on chromosome 12. Genome-wide association studies have repeatedly linked this genomic region to modest variations in blood pressure traits and susceptibility to essential hypertension. Carrying specific alleles at this site is associated with small statistical shifts in vascular tone regulation rather than a direct diagnosis of cardiovascular disease.
What each genotype means
| Genotype | What the research suggests | Reading |
|---|---|---|
| AA | Homozygous for the A allele at rs17247383. In genome-wide association studies, this genotype is typically considered the baseline or reference profile with average population susceptibility to elevated blood pressure. | Informational |
| AG | Heterozygous carrier possessing one copy of the A allele and one copy of the G allele. Research associates this genotype with intermediate statistical trends in vascular tone regulation and blood pressure metrics relative to homozygous baselines. | Informational |
| GG | Homozygous for the alternate G allele at rs17247383. Population studies have linked carrying two copies of this allele to a slightly higher statistical probability of elevated blood pressure and hypertension susceptibility. | Higher attention |
What Is rs17247383 and Where Is It Located?
The genetic variant rs17247383 represents a single nucleotide polymorphism (SNP) situated within or adjacent to the ATP2B1 gene on the long arm of chromosome 12. It consists of an exchange between adenine (A) and guanine (G) base pairs. Like many common variants cataloged in genomic databases like dbSNP, rs17247383 does not disrupt the core coding structure of a protein directly; instead, it is situated in a non-coding region where it may influence how neighboring genes are regulated or expressed. In large-scale genetic studies, this specific SNP frequently serves as a proxy or tagging variant for a block of inherited DNA that travels together through generations. Its primary scientific significance stems from its repeated emergence in population-wide screenings searching for the subtle biological architecture underlying blood pressure variation.
The Biological Function of ATP2B1
The ATP2B1 gene encodes plasma membrane calcium-transporting ATPase 1 (PMCA1), a key cellular pump responsible for extruding calcium ions from the cytoplasm out into the extracellular space. In vascular smooth muscle cells, cytosolic calcium levels are the primary trigger for cellular contraction; when intracellular calcium rises, blood vessels constrict, elevating vascular resistance and raising systemic blood pressure. By actively removing calcium, the PMCA1 enzyme helps vascular smooth muscle relax, keeping vascular tone balanced. Experimental animal models and cellular research have shown that reduced ATP2B1 expression impairs this relaxation mechanism, leading to sustained increases in vascular resistance. Consequently, inherited genetic variations that alter the expression levels or stability of ATP2B1 transcripts can subtly shift an individual's baseline vascular response to physiological stress.
Scientific Evidence and Strength of Association
Multiple international research consortia, including the Global Blood Pressure Genetics (Global BPgen) and CHARGE consortia, have investigated the ATP2B1 locus in tens of thousands of participants. Across diverse cohorts—most notably in East Asian and European populations—common alleles near rs17247383 have demonstrated statistically significant associations with systolic blood pressure, diastolic blood pressure, and essential hypertension risk. However, the evidence strength for rs17247383 as an independent clinical risk factor remains limited. In polygenic traits like blood pressure, single variants typically account for less than a single millimeter of mercury (mmHg) change in resting pressure. While the biological pathway involving calcium extrusion is robust, rs17247383 itself is merely one subtle contributor among hundreds of interacting genetic and environmental factors.
What You Can and Cannot Do With This Information
Discovering your rs17247383 genotype provides educational insight into your inherited biological pathways, but it cannot diagnose hypertension, predict a heart attack, or serve as a standalone medical assessment. Standard clinical evaluations—specifically routine, calibrated blood pressure monitoring by a healthcare provider—remain the only definitive method to evaluate cardiovascular status. Genetic predispositions at loci like ATP2B1 can be heavily modified by environmental and lifestyle factors, including dietary sodium and potassium intake, physical exercise, body composition, and stress management. Furthermore, individuals taking antihypertensive medications should never alter their dosages or treatment regimens based on consumer genetic tests, but should instead consult a licensed clinician or pharmacist for evidence-based cardiovascular management.
How common is this variant?
The minor allele frequency for rs17247383 is roughly 30% to 35% in populations of European ancestry and reaches up to 45% in East Asian populations, making all three genotypes common across global cohorts.
Frequently asked questions
Does having the higher-attention genotype at rs17247383 mean I will develop high blood pressure?
No. Essential hypertension is a complex condition influenced by hundreds of genetic variants alongside diet, exercise, age, and lifestyle habits. Carrying a higher-attention genotype confers only a fractional statistical risk, not a certainty.
How does the ATP2B1 gene influence blood pressure?
ATP2B1 encodes an enzyme that pumps calcium out of vascular smooth muscle cells. Because calcium triggers blood vessel contraction, variations that alter this pumping activity can subtly affect how tightly blood vessels constrict.
Should I change my blood pressure medication based on my rs17247383 result?
Never modify, start, or stop prescribed medications based on genetic results from a consumer test. Always discuss any questions about your blood pressure management or medications directly with your physician or pharmacist.
Why is the association evidence for rs17247383 classified as limited?
While the ATP2B1 locus consistently reaches statistical significance in genome-wide studies, the individual effect size of rs17247383 is modest, and it often acts as a tagging proxy rather than a proven causal mutation on its own.
Sources & further reading
Educational information only, last refreshed 9/7/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs17247383?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29